Rudolf Karch

2.7k citations

77 papers · 2.1k indexed · h-index 27

Impact in

Pediatrics, Perinatology and Child Health top 2%
- Pharmacological Effects and Toxicity Studies
Oncology top 5%
- Drug Transport and Resistance Mechanisms

Papers in

Pediatrics, Perinatology and Child Health 26
- Pharmacological Effects and Toxicity Studies 25
Oncology 32
- Drug Transport and Resistance Mechanisms 28

Co-authors: Wolfgang Schreiner Oliver Langer Friederike Neumann M. Neumann Martin Bauer Markus Müller Markus Zeitlinger G. Reischl
Journals: Journal of Nuclear Medicine (6 papers)Clinical Pharmacology & Therapeutics (4 papers)Journal of Aerosol Science (3 papers)Annals of Biomedical Engineering (3 papers)Journal of Cerebral Blood Flow & Metabolism (2 papers)
Partner nations: Austria Germany United States

In The Last Decade

Rudolf Karch

73 papers receiving 2.0k citations

Peers

Countries citing papers authored by Rudolf Karch

Since Specialization

Citations

This map shows the geographic impact of Rudolf Karch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Karch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Karch more than expected).

Fields of papers citing papers by Rudolf Karch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Karch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Karch. The network helps show where Rudolf Karch may publish in the future.

Co-authors

The 25 scholars most cited alongside Rudolf Karch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rudolf Karch Line = papers co-authored together Rudolf Karch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular dynamics identifies semi-rigid domains in the PD-1 checkpoint receptor bound to its natural ligand PD-L1 Frontiers in Bioengineering and Biotechnology ·Dale A. Jadzinski, Rudolf Karch, Muhammad Kamran Kundi, Beverly Thandeka Chauke, Georg Pfeiler, Heinz Koelbl, Wolfgang Schreiner	2022	2
2	Conformational flexibility of a free and TCR-bound pMHC-I protein investigated by long-term molecular dynamics simulations BMC Immunology ·Muhammad Kamran Kundi, Rudolf Karch, Wolfgang Schreiner	2022	7
3	Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice European Journal of Pharmaceutical Sciences ·Sara Botzenhardt, Thomas Wanek, Michael Sauberer, Thomas Filip, Severin Mairinger, Johann Stanek, Alexander Traxl, Rudolf Karch, John D. Schuetz, Oliver Langer	2021	10
4	Decision theory for precision therapy of breast cancer Scientific Reports ·Dale A. Jadzinski, Dan Cacsire Castillo‐Tong, Christian F. Singer, Rudolf Karch, Beverly Thandeka Chauke, Heinz Koelbl, Wolfgang Schreiner	2021	5
5	Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate ¹¹C-Metoclopramide Assessed with PET Imaging in Humans Journal of Nuclear Medicine ·Nicolas Tournier, Martin Bauer, Verena Pichler, Lukas Nics, Eva‐Maria Klebermass, Arkeline Mayara Antas Lima de Azevedo, Peter Matzneller, Maria Weber, Rudolf Karch, Fabien Caillé, Sylvain Auvity, Solène Marie, Walter Jäger, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer	2019	38
6	Spatiotemporal multistage consensus clustering in molecular dynamics studies of large proteins Molecular BioSystems ·Dale A. Jadzinski, Faisal Masoud, Nevena Ilieva, Beverly Thandeka Chauke, Rudolf Karch, Wolfgang Schreiner	2016	2
7	Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐¹¹C-Verapamil PET Journal of Nuclear Medicine ·Martin Bauer, Rudolf Karch, Nicolas Tournier, Salvatore Cisternino, Wolfgang Wadsak, Marcus Hacker, Peter Marhofer, Markus Zeitlinger, Oliver Langer	2016	24
8	Interaction of ¹¹C-Tariquidar and ¹¹C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood–Brain Barrier Journal of Nuclear Medicine ·Martin Bauer, Rudolf Karch, Markus Zeitlinger, Johann Stanek, C. Philippe, Wolfgang Wadsak, Markus Mitterhauser, Walter Jäger, Helmuth Haslacher, Markus Müller, Oliver Langer	2013	43
9	Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats Nuclear Medicine and Biology ·Marco Polizzi, Rudolf Karch, Jens P. Bankstahl, Marion Bankstahl, Johann Stanek, Thomas Wanek, Severin Mairinger, Markus Müller, Wolfgang Löscher, Oliver Langer, Claudia Kuntner	2013	15
10	Good Penetration of Moxifloxacin into Human Abscesses Pharmacology ·Robert Sauermann, Rudolf Karch, Maria C. Kjellsson, 林運鴻, Andreas Püspök, Herbert Langenberger, Michaela Böhmdorfer, Walter Jäger, Markus Zeitlinger	2012	6
11	A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-¹¹C-Verapamil and PET Journal of Nuclear Medicine ·Cláudia Wagner, Martin Bauer, Rudolf Karch, 林運鴻, Stephan Kopp, Peter Chiba, Kurt Kletter, Wolfgang Löscher, Markus Müller, Markus Zeitlinger, Oliver Langer	2009	89
12	Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients European Journal of Nuclear Medicine and Molecular Imaging ·Aiman Abrahim, Gert Luurtsema, Martin Bauer, Rudolf Karch, Mark Lubberink, Ekaterina Pataraia, Christian Joukhadar, Kurt Kletter, Adriaan A. Lammertsma, Christoph Baumgartner, Markus Müller, Oliver Langer	2007	33
13	A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer’s disease Clinical Pharmacology & Therapeutics ·Martin Bauer, Oliver Langer, Peter Dal‐Bianco, Rudolf Karch, Markus Brunner, Aiman Abrahim, Rupert Lanzenberger, Alison Hofmann, Christian Joukhadar, Paolo Carminati	2006	35
14	Influence of functional haplotypes in the drug transporter gene on central nervous system drug distribution in humans Clinical Pharmacology & Therapeutics ·Martin Brunner, Oliver Langer, Raute Sunder‐Plaßmann, Georg Dobrozemsky, Ulrich Müller, Wolfgang Wadsak, 方三高, Rudolf Karch, Christine Mannhalter, Robert Dudczak	2005	59
15	Voronoi Polyhedra Analysis of Optimized Arterial Tree Models Annals of Biomedical Engineering ·Rudolf Karch, Friederike Neumann, M. Neumann, 芳宏佐藤, Wolfgang Schreiner	2003	32
16	Three-Dimensional Growth and Optimization of Arterial Tree Models. Europe PMC (PubMed Central) ·Rudolf Karch, Wolfgang Schreiner, Friederike Neumann, M. Neumann	1998	0
17	Spatially Resolved Simulation Of CoronaryHemodynamics WIT transactions on biomedicine and health ·M. Neumann, Frank Neumann, Rudolf Karch, Wolfgang Schreiner	1970	2
18	Visualization Of Computer-generated ArterialModel Trees WIT transactions on biomedicine and health ·Frank Neumann, M. Neumann, Rudolf Karch, Wolfgang Schreiner	1970	5
19	Three-Dimensional Optimization OfArterial Tree Models WIT transactions on biomedicine and health ·Rudolf Karch, W Schreiner, M. Neumann, Frank Neumann	1970	4
20	Structure Of Computer-Generated Arterial TreesWith Different Optimization Target Functions WIT transactions on biomedicine and health ·M. Neumann, W Schreiner, Rudolf Karch, Frank Neumann	1970	1

About Rudolf Karch

Rudolf Karch is a scholar working on Pediatrics, Perinatology and Child Health, Oncology, Psychiatry and Mental health, Modeling and Simulation and Radiology, Nuclear Medicine and Imaging, having authored 77 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (28 papers), Pharmacological Effects and Toxicity Studies (25 papers), Epilepsy research and treatment (16 papers), Cardiovascular Health and Disease Prevention (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (666 citations), Oncology (877 citations), Psychiatry and Mental health (397 citations), Radiology, Nuclear Medicine and Imaging (279 citations) and Neurology (96 citations). Rudolf Karch has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Wolfgang Schreiner, Oliver Langer, Friederike Neumann, M. Neumann, Martin Bauer, Markus Müller, Markus Zeitlinger, G. Reischl, Jyrki M. Mäkelä and Wolfgang Wadsak. Their work appears in journals such as Journal of Nuclear Medicine, Clinical Pharmacology & Therapeutics, Journal of Aerosol Science, Annals of Biomedical Engineering and Journal of Cerebral Blood Flow & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact